On February 12, 2026, GSK plc granted deferred bonus awards to various executives, including the CEO and CFO, with a price of £21.50 per share for a total of 28,000 shares. This filing highlights significant remuneration practices in line with their 2017 Deferred Annual Bonus Plan.